Mumbai, the pharmaceutical hub , hosts several significant players in the Carboplatin Active Pharmaceutical Ingredient (API) synthesis landscape. A number of companies , including Cipla, are known to manufacture Carboplatin API (CAS No: 41575-94-4) meeting stringent regulatory standards. These re